Califon, NJ, United States of America

Durrant Cameron


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Durrant Cameron: Innovator in Anti-Seizure Therapy

Introduction

Durrant Cameron is a notable inventor based in Califon, NJ (US). He has made significant contributions to the field of medicine, particularly in the development of anti-seizure therapies. His innovative work has led to the creation of a patent that addresses critical health issues.

Latest Patents

Durrant Cameron holds a patent for his invention, which includes A19-144, A2-73, and certain anticholinesterase inhibitor compositions and methods for anti-seizure therapy. This invention concerns a dosage form comprising a therapeutically effective amount of A19-144 or A2-73 and a therapeutically effective amount of at least one antiepileptic drug (AED). Furthermore, the invention encompasses a method of treating a subject in need of such treatment by administering a therapeutically effective amount of A19-144 or A2-73 in conjunction with a therapeutically effective amount of an AED.

Career Highlights

Durrant Cameron has established himself as a key figure in the pharmaceutical industry. His work at Anavex Life Sciences Corp. has been instrumental in advancing therapeutic options for patients suffering from seizure disorders. His dedication to research and innovation has positioned him as a valuable asset in the field.

Collaborations

Durrant Cameron collaborates with various professionals in the industry, including his coworker, Missling U Christopher. Their combined expertise contributes to the ongoing development of effective treatments for neurological conditions.

Conclusion

Durrant Cameron's contributions to anti-seizure therapy through his innovative patent demonstrate his commitment to improving patient outcomes. His work continues to influence the field of medicine positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…